Abstract
Identifying drugs that control the progression of SARS-CoV-2 and its symptoms has been an urgent research priority during the coronavirus disease 2019
Funding Information
  • This article is published under the Creative Commons Attribution Non-commercial License.

This publication has 6 references indexed in Scilit: